Alpha Teknova, Inc. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Kronos Bio, Inc.

Alpha Teknova, Inc.

Ocuphire Pharma, Inc.

SCYNEXIS, Inc.

FibroGen, Inc.

Capricor Therapeutics, Inc.

CytomX Therapeutics, Inc.

aTyr Pharma, Inc.

Anebulo Pharmaceuticals, Inc.

Werewolf Therapeutics, Inc.

Annovis Bio, Inc.

Why is Alpha Teknova, Inc. ?

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

Poor long term growth as Operating profit has grown by an annual rate -280.10% of over the last 5 years
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -17.29

Positive results in Jun 25

OPERATING CASH FLOW(Y) Highest at USD -9.3 MM
ROCE(HY) Highest at -27.74%
RAW MATERIAL COST(Y) Fallen by -38.76% (YoY)

Risky - Negative EBITDA

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -35.33%, its profits have risen by 21.2%

Falling Participation by Institutional Investors

Institutional investors have decreased their stake by -1.04% over the previous quarter and collectively hold 17.37% of the company
These investors have better capability and resources to analyse fundamentals of companies than most retail investors

Underperformed the market in the last 1 year

Even though the market (S&P 500) has generated returns of 12.33% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -35.33% returns

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Alpha Teknova, Inc. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Alpha Teknova, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Alpha Teknova, Inc.

-40.37%

2.16

75.96%

S&P 500

13.22%

0.61

20.17%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

15.93%

EBIT Growth (5y)

-280.10%

EBIT to Interest (avg)

-17.29

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.15

Sales to Capital Employed (avg)

0.37

Tax Ratio

0.14%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

17.37%

ROCE (avg)

1.15%

ROE (avg)

0.76%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

4.03

EV to EBIT

-13.21

EV to EBITDA

-18.40

EV to Capital Employed

4.55

EV to Sales

7.99

PEG Ratio

Dividend Yield

ROCE (Latest)

-34.43%

ROE (Latest)

-29.63%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bullish

Mildly Bearish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

16What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD -9.3 MM

ROCE(HY)

Highest at -27.74%

RAW MATERIAL COST(Y)

Fallen by -38.76% (YoY

NET SALES(Q)

Highest at USD 10.29 MM

OPERATING PROFIT(Q)

Highest at USD -1.8 MM

OPERATING PROFIT MARGIN(Q)

Highest at -17.46 %

PRE-TAX PROFIT(Q)

Highest at USD -3.55 MM

NET PROFIT(Q)

Highest at USD -3.57 MM

EPS(Q)

Highest at USD -0.07

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Here's what is working for Alpha Teknova, Inc.

Operating Cash Flow

Highest at USD -9.3 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Sales

Highest at USD 10.29 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (USD MM)

Operating Profit

Highest at USD -1.8 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (USD MM)

Operating Profit Margin

Highest at -17.46 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at USD -3.55 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Pre-Tax Profit

At USD -3.55 MM has Grown at 39.1%

over average net sales of the previous four periods of USD -5.83 MM

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit

Highest at USD -3.57 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (USD MM)

EPS

Highest at USD -0.07

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost

Fallen by -38.76% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales